Several weight-loss drugs are now available and new, better versions are being researched all the time The new generation of weight-loss drugs were initially developed to treat diabetes and work by ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...

A first-of-its-kind study has found that women who discontinued GLP-1 medications upon becoming pregnant experienced ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro). The ...

For weight loss, amla emerges as a stronger contender than oranges, with studies showing it significantly reduces body weight ...

Women who have rebound weight gain after stopping Wegovy or similar jabs end up gaining more weight during pregnancy, leading ...

“In general, we tend to see more weight loss with GLP-1-based medication treatment in patients who are female, those who do ...

Sector investors need to weigh potential cost risks with growth potential. That process starts by asking even more questions.

This can be a problem for many reasons, because skeletal muscle is far more than the tissue that helps us move. It plays a crucial role in metabolic health, regulating blood sugar and healthy ageing.